Review: In vitro generation of red blood cells for transfusion medicine: Progress, prospects and challenges

Biotechnol Adv. 2018 Dec;36(8):2118-2128. doi: 10.1016/j.biotechadv.2018.09.006. Epub 2018 Sep 29.

Abstract

In vitro generation of red blood cells (RBCs) has the potential to circumvent the shortfalls in global demand for blood for transfusion applications. The conventional approach for RBC generation has been from differentiation of hematopoietic stem cells (HSCs) derived from cord blood, adult bone marrow or peripheral blood. More recently, RBCs have been generated from human induced pluripotent stem cells (hiPSCs) as well as from immortalized adult erythroid progenitors. In this review, we highlight the recent advances to RBC generation from these different approaches and discuss the challenges and new strategies that can potentially make large-scale in vitro generation of RBCs a feasible approach.

Keywords: Cord blood; Erythroid; Hematopoietic; Immortalized; Induced pluripotent stem cells; Red blood cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Culture Techniques*
  • Cell Differentiation
  • Erythrocytes*
  • Fetal Blood / cytology
  • Hematopoietic Stem Cells
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Mice
  • Transfusion Medicine*